The Boom of Analytics in the Pharma & Healthcare Industry

The Boom of Analytics in the Pharma and Healthcare Industry

An Indian Economic Survey summed it up perfectly by stating how the domestic market is poised to achieve triple-fold growth within the coming decade. The pharmaceutical sector is one of the fastest-growing industries in the country, with excellent future prospects.

RPA (Robotic Process Automation) and more intelligent automation solutions for higher cost and time savings. Blockchain solutions for identification of the return of counterfeit drugs from the pharma market. Innovative technologies for computer-simulated trials and higher testing cycles in lower time, leading to superior results. Analytics (based on workflows) and insights for businesses through leveraging data, along with platforms for tracking compliance, risks, regulatory guidelines, and financial and operational risks.

In this whitepaper, we discussed how analytics aid in opening up multiple benefits through the power of data in the pharma and life sciences industry.

Download The eBook

Please fill out the form below with valid details:

Table of Contents:
- How the Industry Stacks Up
- Emerging Trends in the Pharma Space
- Analytics-Driven Pharma
- Analytics in Pharma Industry
- Analytics in Life Sciences Industry
- How our Analytics Solutions Benefit You
- INT. at a glance
Summary:

This whitepaper explores the impact of analytics in the pharmaceutical and life sciences industry. It discusses the current state of the industry, including emerging trends, and highlights the benefits of using analytics to drive decision-making. The paper also looks at specific applications of analytics in the pharmaceutical and life sciences sectors and outlines how analytics solutions can benefit companies in these industries.
Key Highlights:
- The market is all set to touch USD$65 billion by 2024 and grow to USD$130 billion by 2030
- Even though India becomes one of the world’s biggest pharma markets, challenges will still persist
- Domestic medicine spending is forecasted to grow by 9-12% in India over the upcoming five years